Biokart India
Biokart India is a Bengaluru-based private biotechnology services company founded in 2011 that provides DNA sequencing, fragment analysis, and gene expression profiling services. The firm serves customers requiring outsourced molecular biology and genomics capabilities, operating with 51–100 employees.
- Company typePrivate
- Founded2011
- HeadquartersBengaluru, India
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Biokart India does
Biokart India Pvt. Ltd. is a Bengaluru-based biotechnology services company founded in 2011 that provides molecular biology and genomics services, specifically DNA sequencing, fragment analysis, and gene expression profiling. The firm operates as a private, for-profit entity with a workforce of 51–100 employees, placing it in the small-to-mid-cap tier of India's contract research and genomics services market. Its offerings sit within the outsourced laboratory services segment, serving customers who require molecular profiling capabilities without maintaining in-house sequencing infrastructure.
No detailed product portfolio, pricing model, customer segments, or go-to-market motion is documented in the available source material. The company website (biokart.com) was not fully retrievable at the time of capture, and no certifications, partnerships, patents, leadership disclosures, funding history, or revenue figures were provided. As a result, the business model mechanics — how Biokart prices its sequencing and profiling services, which customer verticals it targets (academic, pharma, clinical diagnostics, agricultural biotech), and whether it operates a fee-for-service, project-based, or subscription model — cannot be confirmed from the inputs.
The 14-year operating history since founding and the sustained 51–100 employee headcount suggest a steady-state service operation rather than a high-growth venture-backed startup, though no funding rounds or investor information are disclosed to corroborate this. For an investment audience, Biokart India currently presents as an opaque small-cap Indian biotech services provider with documented capabilities in core genomics techniques but limited publicly verifiable detail on commercial scale, customer base, technology stack, or strategic direction.
Biokart India firmographics
Firmographics- Name
- Biokart India
- Website
- https://biokart.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biokart India is a Bengaluru-based private biotechnology services company founded in 2011 that provides DNA sequencing, fragment analysis, and gene expression profiling services. The firm serves customers requiring outsourced molecular biology and genomics capabilities, operating with 51–100 employees.
- Ownership category
- akta.pro rank
Biokart India industry classification
Industry- Product category
- Genomics & Molecular Biology Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Transcriptomics & Gene Expression Profiling Services (HLAGANAE)
- akta.pro secondary industries
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
Keywords
Where Biokart India is headquartered
LocationHeadquarters
- HQ city
- Bengaluru
- HQ country
- India
- HQ region
- Asia
Markets served
Biokart India business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Biokart India product offering
Product offeringCore offering
Biokart India Pvt. Ltd. is a biotechnology services company that delivers genomics-based laboratory services, including DNA sequencing, fragment analysis, and gene expression profiling. The firm supports research and clinical customers with molecular biology workflows conducted from its Bengaluru-based facility. Its offering centers on wet-lab execution and reporting for life sciences customers rather than the sale of instruments or reagents.
Differentiator
Problem solved
Functional benefit
Products and services
- DNA Sequencing
- Fragment Analysis
- Gene Expression Profiling
Companies that use Biokart India
Customer profileIdeal customer profiles2 records
Biokart India technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Biokart India competitors and assessment
Company assessmentDirect peers
- Ocimum Biosolutions: India-headquartered genomics and bioinformatics services company offering sequencing, expression profiling, and data analysis — overlapping Biokart's service portfolio with a longer institutional history.
- SciGenom Labs: India-based genomics and next-generation sequencing services company offering targeted sequencing, exome, RNA-seq and expression analysis — a directly comparable peer in the Indian genomics services market.
- MedGenome: India-headquartered genomics services and molecular diagnostics company offering DNA sequencing, fragment analysis, and gene expression profiling — directly overlapping Biokart's core service menu and Bengaluru-based competitor set.
- DNA Labs India: India-based molecular diagnostics and genomics laboratory offering genetic testing and sequencing services, comparable to Biokart on the genomics services side, though tilted toward clinical/diagnostic use cases.
- Strand Life Sciences: Bengaluru-based genomics and bioinformatics services company providing sequencing, expression profiling, and clinical genomics — a close geographic and offering-overlap peer to Biokart.
- Clevergene: Indian genomics services firm offering DNA sequencing, fragment analysis (AFLP, microsatellite), and gene expression profiling — directly comparable service portfolio to Biokart.
- Xcelris Labs: Indian genomics services company (now part of a larger group) offering DNA sequencing, fragment analysis, and gene expression services across agri-biotech and human health — directly comparable offerings to Biokart.
- Genotypic Technology: Bengaluru-based genomics and microarray services provider with offerings in sequencing and expression profiling; overlaps Biokart on both service lines and Bengaluru market.
- Bione India: Bengaluru-based genomics and molecular biology services provider offering sequencing and gene expression services; overlaps Biokart on geography and core service menu.
Broad incumbents
- Eurofins Genomics: Global genomics services powerhouse with operations in India; offers sequencing, genotyping, and gene expression services as part of a much broader life-sciences testing portfolio, competing with Biokart for Indian biotech and academic clients.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights4 records
Customer concentration
Biokart India social profiles
Digital presenceBiokart India financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biokart India leadership team
Management profileNumber of profiles
Biokart India funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biokart India M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biokart India
What does Biokart India do?
Biokart India Pvt. Ltd. is a biotechnology services company that delivers genomics-based laboratory services, including DNA sequencing, fragment analysis, and gene expression profiling. The firm supports research and clinical customers with molecular biology workflows conducted from its Bengaluru-based facility. Its offering centers on wet-lab execution and reporting for life sciences customers rather than the sale of instruments or reagents.
Is Biokart India a public or private company?
Biokart India is a private company. It is classified as unknown and is currently operating.
When was Biokart India founded?
Biokart India was founded in 2011. It employs 11 to 50 people.
Where is Biokart India based?
Biokart India is headquartered in Bengaluru, India, in the Asia region.
Who are Biokart India's main competitors?
Direct peers on record are Ocimum Biosolutions, SciGenom Labs, MedGenome, DNA Labs India, Strand Life Sciences, Clevergene, Xcelris Labs, Genotypic Technology and Bione India. Eurofins Genomics is listed as a broad incumbent.
Does Biokart India have an API?
No public API is recorded for Biokart India.
What industry is Biokart India in?
Biokart India's product category is Genomics & Molecular Biology Services. Its primary akta.pro industry code is HLAGANAE, Transcriptomics & Gene Expression Profiling Services, with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 541714 and its SIC code is 8731.